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Pelvic ﬂoor disorders, including urinary incontinence, pelvic
organprolapse(POP),andboweldysfunction,aﬀectmillions
ofwomenworldwideresultinginconsiderablecostandqual-
ity of life impact. One-third of all women will suﬀer from
these disorders at some point in their lives [1–5]. Signiﬁcant
research eﬀorts are underway to improve our understanding
of the pathophysiology, optimal evaluation, and eﬀective
treatment for women with pelvic ﬂoor disorders. More than
ever before, research is providing meaningful developments
into etiologies and novel treatment modalities. Additionally,
researchers advance our understanding of improved meth-
ods for evaluating treatment outcomes, including patient-
reported outcomes. These advances are largely due to the
eﬀorts of an increasing number of clinician-scientists who
design and conduct high-quality clinical trials and transla-
tional studies. In addition to learning more about basic pa-
thophysiology,recenttechnicaladvancesoﬀerexcellenttreat-
menteﬃcacywithreducedmorbidity.Thisworkisfacilitated
by the eﬀorts of multidisciplinary teams composed of a wid-
ening group of pelvic ﬂoor specialists, including radiologists,
physiotherapists, urologists, and urogynecologists. The clin-
ical advances in urogynecology are advancing rapidly and
will improve the well-being of millions of women who suﬀer
from pelvic ﬂoor disorders.
Themainfocusofthisspecialissueisonnewandexisting
diagnostic and treatment methods for pelvic ﬂoor disorders.
The articles summarize current approaches to the treatment
of these disorders and look into the future by discussing
possible novel interventions for the treatment of pelvic ﬂoor
dysfunction.
Theﬁrstpaperofthisissue,publishedbyagroupofclini-
cians from The Netherlands, explores the association of
POP severity and subjective pelvic ﬂoor symptoms. As one
might expect, presence of POP on exam was associated with
patient-reported symptoms of prolapse and voiding dys-
function, but not with urinary incontinence or defecatory
symptoms. The second paper evaluates the role of pessary
trial in predicting postoperative outcomes of occult stress
urinary incontinence. The authors suggest that pessary trial
is an eﬀective method to evaluate POP patients for occult
stress incontinence, as 20% of patients with occult stress in-
continence were identiﬁed by pessary trial alone. The third
paper presents a comparative study between two common
methods to evaluate aﬀerent neural function in the lower
urinary tract. The current perception test is becoming in-
creasingly important in diagnosing abnormalities of aﬀerent
neural pathways. Since these neurologic problems may con-
tribute to certain pelvic ﬂoor disorders, it is important to es-
tablish the best methods for these neural changes. The au-
thors conclude that the method of levels is superior to the
method of limits when evaluating current perception thresh-
olds in the lower urinary tract. The fourth manuscript re-
views a new treatment for stress urinary incontinence, tran-
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proximal urethra. Radio frequency is thought to reduce fun-
neling of the bladder neck through the denaturation of sub-
mucosal collagen, with a resultant reduction in tissue com-
pliance and increased Valsalva leak point pressure. The
authors conclude that radio frequency is an eﬀective conser-
vative treatment for stress incontinence with few side eﬀects.
In the ﬁfth paper, from the Cleveland Clinic, an animal
model was used to evaluate whether intravenously injected
mesenchymal stem cells home to pelvic organs after simu-
lated childbirth injury. The ﬁndings of this interesting paper
provide evidence that intravenous administration of mesen-
chymal stem cells may be used as an early intervention to
repair injuries to the levator ani muscles and both ure-
thral and ani sphincters, thus preventing future pelvic ﬂoor
disorders.
The sixth paper presents results of an Israeli survey
evaluating trends among Israeli urogynecologists regarding
the routine use of mesh. The use of mesh in vaginal pro-
lapse surgery is a hot topic, especially since the last safety no-
tiﬁcation published by the FDA on July 13, 2011 regarding
possible adverse events following the use of vaginal mesh.
Ironically,theuseofmeshamongIsraeliurogynecologistsin-
creased signiﬁcantly over the last two years. Though the data
regarding the eﬃcacy and safety of vaginal mesh is still lack-
ing, the popularity of this method continues to rise. One
possible explanation for this discrepancy is that Israeli physi-
cians practice medicine in an environment characterized by
innovation and scientiﬁc progress. Until studies with higher
levels of evidence prove the eﬃcacy of these treatments,
more caution should be advised in the application of this yet
unproven technology. The next paper published by Dr. K.
T. Downing is a comprehensive review article regarding the
progress of treatment of uterine prolapse from ancient times
up to the present day. This article is especially relevant for
those who are looking for new advances in medicine. As was
stated previously by George Santayana, “Those who cannot
remember the past are condemned to repeat it.”
Last but not least is a paper published by a group of re-
searchers from Spain who evaluated the level of training of
residents in obstetrics and gynecology in the management
of perineal tears that occur during assisted vaginal delivery.
Almost all of the respondents indicated that more training
in this speciﬁc area is necessary (98%). As Ralph Waldo
Emerson once stated, “Skill to do comes of doing.”
Finally, in this special issue, the reader will conveniently
ﬁnd a comprehensive summary of the state-of-the-art diag-
nostic strategies and new advances in urogynecology.
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